-
Mashup Score: 2
Study from the Journal of Hepatology aims to characterize immune responses associated with rapid natural clearance of HCV reinfection.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1Preventing Mother-to-Child Transmission of Hepatitis C - 1 month(s) ago
Insights on Sofosbuvir levels in pregnant women.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0
Treatment with DAA therapy at 3 years of age was associated with better health outcomes and cost savings versus deferring initiation to 6 years of age or older.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Lung Transplant With HCV-Viremic Organ Does Not Increase Rejection, Allograft Dysfunction - 2 month(s) ago
All patients who received an HCV+ organ achieved SVR12 and had lower rates of rejection and chronic lung allograft dysfunction compared to uninfected donor organ recipients.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Global Access to Hepatitis C Treatments - 2 month(s) ago
Accessibility to direct-acting antivirals affecting low and middle-income countries.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0Achieving SVR May Not Reduce Risk of HCC in Patients with HCV - 3 month(s) ago
Findings suggest the risk of hepatocellular carcinoma may persist in patients with HCV, even after achieving SVR with direct-acting antiviral therapy.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Pan-Genotypic DAA Regimens Safe, Effective for Children, Adolescents with Chronic HCV - 3 month(s) ago
Results of the systematic review and meta-analysis support the use of pan-genotypic DAA regimens for the treatment of chronic HCV in adolescents and children ≥ 3 years of age.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Pan-Genotypic DAA Regimens Safe, Effective for Children, Adolescents with Chronic HCV - 3 month(s) ago
Results of the systematic review and meta-analysis support the use of pan-genotypic DAA regimens for the treatment of chronic HCV in adolescents and children ≥ 3 years of age.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2American Academy of HIV Medicine | Clinical Research Update - 3 month(s) ago
The American Academy of HIV Medicine’s “Clinical Research Update” features clinical information from Carolyn Chu, MD, MSc, AAHIVS who serves as chief medical officer for the Academy. Dr. Chu provides a short synopsis of key clinical studies, reviews, and clini cal practice guidelines selected on the basis of having immediate or important clinical implications for our Academy members and their patients. Periodic updates from the U.S. Department of Health and Human Services (DHHS) HIV Clinical Practice
Source: aahivm.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0
Although the overall response rate among the cohort was 96.4%, this figure dropped as low as 66.7% when accounting for male gender, GT3 infection, cirrhosis, obesity, and non-response to previous therapy.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
.@JHepatology aims to characterize immune responses associated with rapid natural clearance of Hepatitis C #HCV reinfection. https://t.co/jLWG9heuvv https://t.co/bUuOJFDtjB